Concepedia
Statistics
Publications
7
Citations
158
H-Index
Active since
2017
Affiliations
University of Delaware(Current)
Merck & Co., Inc., Rahway, NJ, USA (United States)
Bristol-Myers Squibb (United States)
Andrew R. Swartz is an author at University of Delaware specializing in biotechnology, antibody characterization, and immunotechnology.
Publications per year
2017–2024
SpyTag/SpyCatcher Functionalization of E2 Nanocages with Stimuli-Responsive Z-ELP Affinity Domains for Tunable Monoclonal Antibody Binding and Precipitation Properties
Andrew R. Swartz, Wilfred Chen · Bioconjugate Chemistry · 2018 · 32 citations
Pharmacy, Biochemistry, Biotechnology +17
Ligand-Induced Cross-Linking of Z-Elastin-like Polypeptide-Functionalized E2 Protein Nanoparticles for Enhanced Affinity Precipitation of Antibodies
Andrew R. Swartz, Qing Sun, Wilfred Chen · Biomacromolecules · 2017 · 31 citations
Life Sciences, Biochemistry, Biotechnology +16
One‐step affinity capture and precipitation for improved purification of an industrial monoclonal antibody using Z‐ELP functionalized nanocages
Andrew R. Swartz, Xuankuo Xu, Steven J. Traylor et al. · Biotechnology and Bioengineering · 2017 · 30 citations
Improved mRNA affinity chromatography binding capacity and throughput using an oligo-dT immobilized electrospun polymer nanofiber adsorbent
Emily A. Dewar, Peter Guterstam, David A. Holland et al. · Journal of Chromatography A · 2024 · 23 citations
Life Sciences, Biotechnology, Molecular Biology +14
High‐efficiency affinity precipitation of multiple industrial mAbs and Fc‐fusion proteins from cell culture harvests using Z‐ELP‐E2 nanocages
Andrew R. Swartz, Xuankuo Xu, Steven J. Traylor et al. · Biotechnology and Bioengineering · 2018 · 16 citations
Pharmacy, Biotechnology, Immunology +17
1–5 of 7